SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.522
AS - Asia 5.447
EU - Europa 3.220
SA - Sud America 731
AF - Africa 109
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.042
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.305
SG - Singapore 2.102
CN - Cina 1.411
DE - Germania 839
VN - Vietnam 615
BR - Brasile 568
UA - Ucraina 518
IT - Italia 409
GB - Regno Unito 383
HK - Hong Kong 369
FI - Finlandia 341
TR - Turchia 327
FR - Francia 186
BD - Bangladesh 145
RU - Federazione Russa 138
CA - Canada 120
IN - India 119
JP - Giappone 115
SE - Svezia 115
MX - Messico 69
PL - Polonia 65
AR - Argentina 46
ZA - Sudafrica 46
NL - Olanda 45
IQ - Iraq 40
BE - Belgio 39
ES - Italia 34
PK - Pakistan 31
LT - Lituania 28
ID - Indonesia 27
CO - Colombia 26
EC - Ecuador 25
UZ - Uzbekistan 21
VE - Venezuela 20
SA - Arabia Saudita 19
MA - Marocco 18
AE - Emirati Arabi Uniti 16
CZ - Repubblica Ceca 16
MY - Malesia 13
PH - Filippine 12
PY - Paraguay 12
CL - Cile 11
TN - Tunisia 11
AT - Austria 9
NP - Nepal 9
PE - Perù 9
UY - Uruguay 9
AU - Australia 8
EG - Egitto 8
IL - Israele 8
CH - Svizzera 7
IR - Iran 7
JM - Giamaica 7
JO - Giordania 7
DO - Repubblica Dominicana 6
IE - Irlanda 6
KE - Kenya 6
AL - Albania 5
BG - Bulgaria 5
BO - Bolivia 5
GR - Grecia 5
KR - Corea 5
RO - Romania 5
ET - Etiopia 4
HR - Croazia 4
KZ - Kazakistan 4
SN - Senegal 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AZ - Azerbaigian 3
BH - Bahrain 3
CR - Costa Rica 3
DZ - Algeria 3
LB - Libano 3
NO - Norvegia 3
SV - El Salvador 3
TH - Thailandia 3
BB - Barbados 2
BJ - Benin 2
CY - Cipro 2
DK - Danimarca 2
HN - Honduras 2
KH - Cambogia 2
LK - Sri Lanka 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
AM - Armenia 1
BF - Burkina Faso 1
BY - Bielorussia 1
CG - Congo 1
CV - Capo Verde 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 21.030
Salva come PNG Salva come JPEG
Città #
Singapore 1.401
Ashburn 1.323
Fairfield 1.156
Woodbridge 1.108
Houston 673
San Jose 642
Jacksonville 577
Ann Arbor 564
Chandler 513
Seattle 444
Beijing 442
Santa Clara 425
Wilmington 411
Cambridge 379
Hong Kong 364
Munich 340
Ho Chi Minh City 204
Los Angeles 188
New York 186
Izmir 185
Helsinki 155
Nanjing 154
Dallas 141
Hanoi 133
Milan 124
Princeton 113
Tokyo 111
San Diego 103
Boardman 100
Lauterbourg 97
Shanghai 90
São Paulo 72
Turku 72
Ferrara 61
Nanchang 61
Orem 59
London 56
Dearborn 55
Warsaw 55
Shenyang 47
Frankfurt am Main 46
Buffalo 42
Mexico City 38
Brussels 37
Brooklyn 36
Denver 36
Hebei 35
Bremen 34
Atlanta 33
Falkenstein 33
Tianjin 33
Toronto 31
Da Nang 29
Hefei 29
Montreal 29
Chennai 28
Chicago 28
Johannesburg 27
Auburn Hills 25
Haiphong 25
Jiaxing 24
Mountain View 24
San Mateo 24
Manchester 23
Rio de Janeiro 23
Falls Church 22
Mcallen 22
Stockholm 22
The Dalles 22
Norwalk 21
Dhaka 20
Philadelphia 20
Phoenix 20
Tashkent 20
Amsterdam 19
Boston 19
Changsha 19
Mumbai 19
Baghdad 18
Jinan 18
Moscow 18
San Francisco 18
Bologna 17
Montréal 17
Zhengzhou 17
Addison 16
Poplar 16
Redwood City 15
Kunming 14
Lahore 14
Guangzhou 13
Jeddah 13
Tappahannock 13
Hải Dương 12
Indiana 12
Washington 12
Belo Horizonte 11
Biên Hòa 11
Curitiba 11
Ankara 10
Totale 14.737
Salva come PNG Salva come JPEG
Nome #
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 394
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 317
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 290
A new selective antagonist of the nociceptin receptor 273
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 272
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 269
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 269
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 267
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 263
Effects of vasoactive agents in healthy and diseased human saphenous veins 263
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 261
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 259
A new ligand for the urotensin II receptor 254
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 253
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 251
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4′-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide 239
Ala scan analogues of HOE 140. Synthesis and biological activities 239
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 235
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 234
Nociceptin/orphanin FQ receptor knockout rats: In vitro and in vivo studies 233
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 233
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 226
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 224
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 222
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 221
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 220
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 216
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 215
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24 215
Pharmacological characterization of tachykinin tetrabranched derivatives 215
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 214
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 213
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 212
B1 and B2 kinin receptors in various species 212
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 212
Pharmacological characterisation of novel kinin B2 receptor ligands 211
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 211
Further studies at neuropeptide S position 5: Discovery of novel neuropeptide S receptor antagonists 208
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 206
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 206
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 205
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 204
Pharmacological characterization of nociceptin receptor: an in vitro study 204
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 203
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 202
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 201
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 200
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists 199
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 199
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]neuropeptide S 198
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 197
Structure-activity study at positions 3 and 4 of human neuropeptide S. 195
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 194
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 191
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 190
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 189
Anxiolytic-like effect of neuropeptide S in the rat defensive burying 185
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 184
Characterization of the human vascular kinin B2 receptor by binding assays. 181
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 180
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 179
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 178
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 178
Nociceptin/orphanin FQ receptor ligands 177
Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist 177
Structure-activity relationship study on human urotensin II 176
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 170
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 170
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 167
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 166
Characterization of endothelin receptors in the human umbilical artery and vein 165
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 163
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 163
Pharmacology of nociceptin and its receptor: a novel therapeutic target 162
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 162
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 161
In vitro pharmacological profile of peptide III-BTD: A novel ligand for nociceptin/orphanin FQ and opioid receptors 161
Pharmacology of the Kallikrein-Kinin system 157
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 157
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 156
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 156
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 156
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 156
Receptors for kinins in the human isolated umbilical vein 153
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 153
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 152
Endogenous nociceptin signaling and stress-induced analgesia 150
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 149
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 142
In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative 141
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 141
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 139
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 138
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 137
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 133
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 131
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 129
Characterization of the human vascular kinin B2 receptor by binding assays 128
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 119
Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues 2. In vivo studies 114
Totale 19.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.462
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202168 0 0 0 0 0 0 0 0 0 0 0 68
2021/20221.209 45 117 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20252.838 67 70 209 108 326 315 126 171 418 239 430 359
2025/20267.555 849 329 619 1.013 1.132 476 892 377 707 719 320 122
Totale 21.142